DBV Technologies: Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2024
(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)
Market : NYSE Euronext Paris
ISIN Code: FR 0010417345
Date | Total number of shares | Total number of voting rights |
| 11/30/2024 | 102,847,501 | Total gross of voting rights: 102,847,501 |
Total net* of voting rights: 102,582,335 |
* Net total = total number of voting rights attached to shares – shares without voting rights
| Last Trade: | US$7.78 |
| Daily Change: | -0.13 -1.64 |
| Daily Volume: | 23,112 |
| Market Cap: | US$159.650M |
January 08, 2025 December 11, 2024 November 06, 2024 | |
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MORE
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORE
